Mice deficient in endothelial nitric oxide synthase (eNOS/Nos3) are widely used as a model to examine the development of DKD and the impact of novel intervention therapies (Takahashi and Harris, 2014; Tesch et al. 2015). The gene discussed is NOS3; the disease is diabetic kidney disease.